与非型MAFLD相关的肝细胞癌的特征:一项回顾性队列研究
Shadi Zerehpooshnesfchi1, Fatema Safri1, Ziyan Pan1
1Storr Liver Centre, The Westmead Institute for Medical Research, Westmead, NSW, Australia.
Therapeutic advances in chronic disease
|May 19, 2025
概括
在没有肝硬化的代谢功能障碍相关的脂肪肝疾病 (MAFLD) 中,肝细胞癌 (HCC) 呈现出明显的临床和瘤特征. 非肝硬化MAFLD-HCC患者出现更具侵略性的瘤,表明独特的疾病驱动因素.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 代谢疾病 代谢疾病
背景情况:
- 肝细胞癌 (HCC) 是一个重要的全球健康问题.
- 非病毒性病因,特别是与代谢 (功能障碍) 相关的脂肪肝疾病 (MAFLD),是HCC的越来越常见的原因.
- 在没有肝硬化的MAFLD患者中,HCC的特征尚不清楚.
研究的目的:
- 调查非肝硬化MAFLD相关的HCC的临床,瘤和遗传特征.
- 为了将这些特征与MAFLD相关的HCC进行比较,这种HCC在肝硬化存在时会发展.
主要方法:
- 一项多中心的回顾性研究,涉及89名MAFLD相关的HCC患者 (2009-2023年).
- 在非肝硬化和肝硬化MAFLD-HCC组之间的临床和瘤特征的比较.
- 统计分析,包括后勤回归,以确定瘤特征的独立预测因素.
主要成果:
- 非肝硬化MAFLD-HCC患者的BMI较低,甘油三水平较高,吸烟率比肝硬化患者更高.
- 非肝硬化MAFLD-HCC的瘤更具侵略性,具有更大的尺寸,多焦点性和门静脉血栓形成.
- 非肝硬化状态独立预测了较大的瘤大小和损伤数量的增加.
结论:
- 在没有肝硬化的情况下,MAFLD相关的HCC表现出独特的临床和瘤特征.
- 这些独特的特征表明了新的,尚未发现的疾病驱动因素的参与.
- 需要进一步的研究来阐明驱动非肝硬化MAFLD-HCC的具体机制.
更多相关视频
08:15A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024
701
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.2K
相关概念视频
01:23Cirrhosis I: Introduction
32
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
32
01:24Cirrhosis II: Pathophysiology
53
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
53